ZBIO
Zenas BioPharma, Inc.After hours25.16−1.24 −4.70%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 25.16 0.00%
Open
26.11
Prev close
26.40
Day range
25.0427.00
52-week range
13.5044.60
Volume
519.65K0.72×
Mkt cap
1.64B
P/E ttm
—
Fwd P/E
-5.40
EPS ttm
-9.63
Div yield
0.00%
Earnings
Aug 13, 2026
From 52w high
−43.59%
ZBIO earnings and estimates
ZBIO Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 12
Before the open · estimated
EPS consensus
$−1.27
range −1.31 – −1.23
EPS growth vs year ago
−4.1%
year ago −1.22
Revenue consensus
$0
0.0% vs year ago
Options-implied move
±24.4%
by Nov 20 · ATM straddle
Past 4 reactions
±3.9%
average move · beat 1 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 13, 2026 BMO | −1.77 | −0.76 | −134.44% | $1.00M | −6.7% | −0.1% |
| Mar '26 | May 13, 2026 BMO | −1.46 | −1.54 | +5.19% | $0 | +4.0% | −6.9% |
| Dec '25 | Mar 16, 2026 BMO | −1.39 | −1.19 | −16.80% | $0 | −3.4% | −7.2% |
| Sep '25 | Nov 12, 2025 BMO | −1.22 | −0.85 | −44.09% | $0 | +1.7% | +2.9% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −1.27 | −1.31−1.23 | −4.1% | $0 | 0.0% | −1.31 +3.1% | −1.31 +3.1% | 1 / 1 |
| Next quarter Dec 2026 | −1.28 | −1.31−1.25 | +7.9% | $14.07M | 0.0% | −0.89 −44.6% | −0.89 −44.6% | 0 / 2 |
| Current year Dec 2026 | −5.62 | −5.83−5.40 | −16.2% | $12.26M | +22.6% | −4.29 −30.7% | −4.33 −29.6% | 0 / 2 |
| Next year Dec 2027 | −4.66 | −5.11−4.21 | +17.0% | $57.93M | +372.5% | −2.27 −105.7% | −2.27 −105.7% | 0 / 2 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −1.23 | −1.31−1.08 | 3 | 0 / 0 |
| Dec 2026 | −1.27 | −1.31−1.19 | 3 | 0 / 0 |
| Mar 2027 | −1.33 | — | 1 | 0 / 0 |
| Jun 2027 | −0.21 | — | 1 | 0 / 0 |
| Sep 2027 | −1.17 | — | 1 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −5.81 | −5.83−5.78 | 3 | 0 / 0 |
| Dec 2027 | −4.87 | −5.11−4.48 | 3 | 0 / 0 |
| Dec 2028 | −3.82 | −4.24−3.42 | 3 | 0 / 0 |
| Dec 2029 | −2.88 | −3.04−2.72 | 2 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.